 |
|
|
|
 |
|
|
Small molecule anti-genomic therapeutics
Small molecule anti-genomic therapeutics, or SMAT, refers to a biodefense technology that targets DNA signatures found in many biological warfare agents. SMATs are new, broad-spectrum drugs that unify antibacterial, antiviral and anti-malarial activities into a single therapeutic that offers substantial cost benefits and logistic advantages for physicians and the military.
References
Levine, Daniel S. (2003). "Bio-defense company re-ups". San Francisco Business Times. Retrieved September 6, 2006.
|
| |
|
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Small_molecule_anti-genomic_therapeutics". A list of authors is available in Wikipedia.
|
Additional information matching your search term
Additional information was found matching your search for Small molecule anti-genomic therapeutics.
|
|
|
|
|
Top